[Overview of clinical applications of urotensin II].
Imaki
Toshihiro
T
Department of Bioregulation, Institute of Development and Aging Sciences, Nippon Medical School.
Tanabe
Akiyo
A
Naruse
Mitsuhide
M
D000818:Animals; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003925:Diabetic Angiopathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015195:Drug Design; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D014579:Urotensins / Q000037:antagonists & inhibitors* / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
D015415:Biomarkers; D014579:Urotensins; C029677:urotensin II